CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-07 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise 10b5-1 | +14,129 | $2.03 | $29K | 450,011 |
| 2024-11-07 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise 10b5-1 | +16,000 | $5.35 | $86K | 466,011 |
| 2024-11-07 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −663 | 0 | ||
| 2024-11-07 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −14,129 | 153,198 | ||
| 2024-11-07 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −16,000 | 202,717 | ||
| 2024-11-07 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Grant or award · Performance Stock Option (right to buy) 10b5-1 | +197,784 | 197,784 | ||
| 2024-11-07 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Grant or award · Performance Restricted Stock Units 10b5-1 | +80,625 | 80,625 | ||
| 2024-11-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise 10b5-1 | +5,000 | $21.41 | $107K | 33,623 |
| 2024-11-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −788 | $104.80 | $83K | 32,835 |
| 2024-11-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −1,415 | $105.72 | $150K | 31,420 |
| 2024-11-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −1,524 | $106.82 | $163K | 29,896 |
| 2024-11-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −1,273 | $107.50 | $137K | 28,623 |
| 2024-11-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 164,497 | ||
| 2024-11-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −9,955 | $106.35 | $1.1M | 440,264 |
| 2024-11-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −3,312 | $107.34 | $356K | 436,952 |
| 2024-11-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −1,733 | $108.50 | $188K | 435,219 |
| 2024-11-01 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +8,000 | $2.42 | $19K | 213,695 |
| 2024-11-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −4,955 | $106.34 | $527K | 208,740 |
| 2024-11-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −2,174 | $107.20 | $233K | 206,566 |
| 2024-11-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −631 | $108.25 | $68K | 205,935 |
Page 18 of 39 · 764 trades